Fresh Recalls

FDANot Yet Classified · Drug · FDA event 99463; recall number pending · Recalled August 19, 2026

Cefazolin in Dextrose recall — Baxter Healthcare Corporation

Agency report date: August 19, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Cefazolin in Dextrose
Company / brand
Baxter Healthcare
Lot / serial / date codes
Lot # LD175708, Exp Date: 14-Feb-2027.
Distribution
US Nationwide.
Agency product description and boundaries

Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Presence of Particulate Matter

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Affected product: Cefazolin in Dextrose

3. Open the official notice or contact

Official recall ID
Not yet assigned by the FDA — identified by FDA event ID 99463
Brand
Baxter Healthcare
Classification
Not Yet Classified
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Deerfield, IL, United States
Firm address
1 Baxter Pkwy, 60015-4625

Identifying details (verbatim from the notice)

Product codes / lots
Lot # LD175708, Exp Date: 14-Feb-2027.
Distribution
US Nationwide.
Firm notified the public via
Letter
FDA event ID
99463
Recall initiated
July 24, 2026
FDA report date
August 19, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page